Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mast cells: A double-edged sword in cancer
Afshin Derakhshani, Fatemeh Vahidian, Mohammad Ali‐Hassanzadeh, et al.
Immunology Letters (2019) Vol. 209, pp. 28-35
Closed Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Xiaoqi Mao, Jin Xu, Wei Wang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 1403
Clinical relevance of tumour-associated macrophages
Mikaël J. Pittet, Olivier Michielin, Denis Migliorini
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 402-421
Closed Access | Times Cited: 460
Targeting CAFs to overcome anticancer therapeutic resistance
Phei Er Saw, Jianing Chen, Erwei Song
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 527-555
Closed Access | Times Cited: 125
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 82
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review
Yu Li, Cangang Zhang, Aimin Jiang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 28
Overcoming trastuzumab resistance in HER2‐positive breast cancer using combination therapy
Afshin Derakhshani, Zohreh Rezaei, Hossein Safarpour, et al.
Journal of Cellular Physiology (2019) Vol. 235, Iss. 4, pp. 3142-3156
Closed Access | Times Cited: 104
Crosstalk between cancer‐associated fibroblasts and immune cells in cancer
Yuan-Yuan An, Fengtian Liu, Ying Chen, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 24, Iss. 1, pp. 13-24
Open Access | Times Cited: 82
Remodeling tumor microenvironment with natural products to overcome drug resistance
Wanlu Zhang, Shubo Li, Chunting Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Targeting the innate immune system in pediatric and adult AML
Alicia Perzolli, Joost B. Koedijk, C. Michel Zwaan, et al.
Leukemia (2024) Vol. 38, Iss. 6, pp. 1191-1201
Open Access | Times Cited: 14
Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer
Junnan Guo, Du Chen, Shen-Hui Deng, et al.
Cancer Immunology Immunotherapy (2021) Vol. 71, Iss. 6, pp. 1313-1330
Open Access | Times Cited: 52
Histamine in cancer immunology and immunotherapy. Current status and new perspectives
María de la Paz Sarasola, Mónica A. Táquez Delgado, Melisa B. Nicoud, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 46
Pathophysiological Roles of Histamine Receptors in Cancer Progression: Implications and Perspectives as Potential Molecular Targets
Phuong Linh Nguyen, Jungsook Cho
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1232-1232
Open Access | Times Cited: 45
Fibroblast diversity and plasticity in the tumor microenvironment: roles in immunity and relevant therapies
Yashi Xu, Wei Li, Shitong Lin, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Overcoming anti-PD-1/PD-L1 immune checkpoint blockade resistance: the role of macrophage, neutrophils and mast cells in the tumor microenvironment
Louis Boafo Kwantwi
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3077-3091
Closed Access | Times Cited: 20
Microenvironmental regulation in tumor progression: Interactions between cancer-associated fibroblasts and immune cells
Dandan Gao, Liguang Fang, Cun Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115622-115622
Open Access | Times Cited: 20
Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma
Xiaodong Yang, Yu Shi, Ming Li, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 43
Recent advances in mast cell activation and regulation
Hwan Soo Kim, Yu Kawakami, Kazumi Kasakura, et al.
F1000Research (2020) Vol. 9, pp. 196-196
Open Access | Times Cited: 43
Metabolic alterations in the tumor microenvironment and their role in oncogenesis
Lihie Eisenberg, Michal Eisenberg‐Bord, Avital Eisenberg‐Lerner, et al.
Cancer Letters (2020) Vol. 484, pp. 65-71
Closed Access | Times Cited: 42
Emerging Roles of Mast Cells in the Regulation of Lymphatic Immuno-Physiology
Sarit Pal, Shubhankar Nath, Cynthia J. Meininger, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 40
Immune cell-derived small extracellular vesicles in cancer treatment
Sung-Jin Choi, Hanchae Cho, Kyungmoo Yea, et al.
BMB Reports (2022) Vol. 55, Iss. 1, pp. 48-56
Open Access | Times Cited: 24
Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy
Mohammad Fereydouni, Elnaz Ahani, Parth Desai, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 24
Identification and Validation of the Prognostic Panel in Clear Cell Renal Cell Carcinoma Based on Resting Mast Cells for Prediction of Distant Metastasis and Immunotherapy Response
Su Yang, Tianxiang Zhang, Jinsen Lu, et al.
Cells (2023) Vol. 12, Iss. 1, pp. 180-180
Open Access | Times Cited: 15
Stromal infiltrating mast cells identify immunoevasive subtype high-grade serous ovarian cancer with poor prognosis and inferior immunotherapeutic response
Kankan Cao, Guodong Zhang, Xiangyun Zhang, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 29
PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy
Jun Li, Gang Peng, Kuikui Zhu, et al.
Cancer Immunology Immunotherapy (2022) Vol. 72, Iss. 3, pp. 633-645
Open Access | Times Cited: 22
Ferroptosis-Related Gene MT1G as a Novel Biomarker Correlated With Prognosis and Immune Infiltration in Colorectal Cancer
Bi Peng, Jinwu Peng, Fanhua Kang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top